CLINICAL_TRIALS
withdrawal
· 2017-11-06
Clinical Trial Update: Midodrine During Recovery From Septic Shock [Phase 4]
Summary
Phase 4 trial evaluating midodrine for recovery from septic shock has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwell Health | Conditions: Hypotension, Shock, Septic | Phase 4 | Status: WITHDRAWN